Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system

• Hoofdauteurs: Wei Wei (Auteur), Li Chen (Auteur), Hui Zhou (Auteur), Jinfeng Liu (Auteur), Yue Zhang (Auteur), Shiyu Feng (Auteur), Yingtao Bai (Auteur), Yanen Leng (Auteur), En Chang (Auteur), Liang Huang (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Methylphenidate, atomoxetine, and Amphetamine are the three most commonly used medications approved by the United States Food and Drug Administration (FDA) for the treatment of attention deficit/hyperactivity disorder (ADHD). However, a comprehensive analysis of their safety profiles acr...